Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamdouh Skafi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cells|July 13, 2026
Ferroptosis in Lymphoproliferative DisordersSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|March 7, 2026
Management of Primary Refractory Diffuse Large B-Cell Lymphoma in Patients Unsuitable for CAR T-Cell TherapySantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
British Journal of Haematology|March 29, 2026
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integrationSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
Expert Opinion on Pharmacotherapy|November 19, 2019
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphomaFortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, et al.
European Journal of Haematology|April 20, 2026
From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL ManagementEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
European Journal of Haematology|April 27, 2026
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic MalignanciesSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Nutrients|May 13, 2026
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational OpportunitiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|June 23, 2026
Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision-MakingMamdouh Skafi, Santino Caserta, Enrica Antonia Martino, et al.
Expert Opinion on Investigational Drugs|June 20, 2020
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitorsFortunato Morabito, Massimo Gentile, Paola Monti, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cells|July 13, 2026
Ferroptosis in Lymphoproliferative DisordersSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|March 7, 2026
Management of Primary Refractory Diffuse Large B-Cell Lymphoma in Patients Unsuitable for CAR T-Cell TherapySantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
British Journal of Haematology|March 29, 2026
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integrationSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
Expert Opinion on Pharmacotherapy|November 19, 2019
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphomaFortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, et al.
European Journal of Haematology|April 20, 2026
From Time-Limited Therapy to Treatment-Free Observation: The Evolving Role of MRD in CLL ManagementEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
European Journal of Haematology|April 27, 2026
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic MalignanciesSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Nutrients|May 13, 2026
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational OpportunitiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|June 23, 2026
Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision-MakingMamdouh Skafi, Santino Caserta, Enrica Antonia Martino, et al.
Expert Opinion on Investigational Drugs|June 20, 2020
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitorsFortunato Morabito, Massimo Gentile, Paola Monti, et al.
Pageof 2